Abstract LB002: Development of fully human anti-CD19 &CD22 bispecific tandem CAR-T for the treatment of resistant or relapsed B cell malignancies
Year: 2022
Type: conference-abstract
Source: Cancer Research
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4282983758
